Cargando…
Dalbavancin: a novel antimicrobial
The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral administration of antimicrobials has inspired the development of a novel antibiotic. Dalbavancin is the first once a week antibiotic with activity against a broad range of Gram-positiv...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1890846/ https://www.ncbi.nlm.nih.gov/pubmed/17362476 http://dx.doi.org/10.1111/j.1742-1241.2007.01318.x |